Browsing Category

Health

Health

7 Wards Identified as Hot Spots in Guwahati, Possibility of Ward-Wise Lockdown

GUWAHATI: “114 people have tested positive in Guwahati in the past 2 days. These people do not have any travel history and were found in the 12 COVID-19 screening centres set up in the city,” said health minister Himanta Biswa Sarma in a press conference on June 22.

Also, 36 more cases were found from the various containment zones of the city and 4 were found in the regular screenings held at GMCH and MMC.

{{XNEQzJ3t7mkXDj6XAKuX}}

Saying that community transmission in Guwahati is worrisome, the health ministry has asked the district administration to implement ward-wise lockdown in the next few days if situations turn for the worse.

7 wards in Guwahati are demarcated as hot spots by the health minister; these are:

• Ward 2: Pandu

• Ward 3: Jalukbari

• Ward 4: Adabari

• Ward 5: Durga Sarobar

• Ward 10: Gauhati Club

• Ward 15: Ambari, Fatasil

• Ward 16: Rupnagar

As of now 31 people from Jalukbari, 69 from Fatasil Ambari area, 51 from Bharalumukh and 25 from Panbazar have been tested positive, these areas were demarcated as ‘Point of Concern’ by Sarma.

“Fancy Bazar is a major hot spot. Most positive cases are somehow found to have some connection with the area. Surely more people of the area are carriers of the disease,” said Sarma.

Further the minister urged people of Fancy Bazar to show up for voluntary screening.

Sarma further added, “The situation in Guwahati is not yet critical, although worrisome. Campaigns need to be done on the COVID-19 protocols like wearing mask, social distancing and others. If people are not careful, the situation in Guwahati might turn critical in about a week.” ( Guwahati Plus)

Health

Glenmark announces launch of Favipiravir to treat Covid-19

Glenmark Pharmaceuticals on Saturday announced the launch of antiviral drug Favipiravir (brand name FabiFlu®) for the treatment of mild to moderate Covid-19 patients.

Glenmark has received manufacturing and marketing approval from India’s drug regulator, making FabiFlu® the first oral Favipiravir-approved medication in India for the treatment of Covid-19, officials said at a press conference organised online.

Favipiravir is backed by strong clinical evidence showing encouraging results in patients with mild to moderate Covid-19.

The antiviral offers broad spectrum RNA virus coverage with clinical improvement noted across age groups 20 to >90 years. Favipiravir can be used in Covid-19 patients with co-morbid conditions such as diabetes and heart disease with mild to moderate Covid-19 symptoms. It offers rapid reduction in viral load within four days and provides faster symptomatic and radiological improvement.

Of most importance, Favipiravir has shown clinical improvement of up to 88 per cent in mild to moderate Covid-19 cases, an official statement said.

Glenn Saldanha, Chairman and Managing Director of Glenmark Pharmaceuticals Ltd, said FabiFlu® has demonstrated an encouraging response in mild to moderate Covid-19 patients during clinical trials.

Health

Favipiravir and Remdesivir get approval for treatment

NEW DELHI/MUMBAI:The Drug Controller General of India (DCGI) has granted permission to manufacture and sell Glenmark pharmaceuticals’ Favipiravir for Covid-19. The approval for Favipiravir 200 mg tablet has been given following the recommendation of special subject expert committee (SEC) on Covid-19.

“Under an accelerated approval process at the Central Drugs Standard Control Organisation (CDSCO), the SEC has recommended the grant of permission to manufacture and market Glenmark’s Favipiravir, 200 mg tablet,” sources added.

“Glenmark Pharmaceuticals has received the manufacturing and marketing approval from India’s drug regulator to launch the oral antiviral drug Favipiravir (FabiFlu®) for the treatment of mild to moderate Covid-19 patients in India,” said the company in a statement.

Reportedly, each strip containing 34 tablets will come at an approximate MRP of Rs 3,500. For the treatment 122 tablets will be required for 14 days.

The approval comes with a caveat that the company will have to submit a copy of the informed consent and report of the ongoing clinical trials within three months. The SEC has also recommended that the drug should be used with caution in patients with a history of abnormalities in metabolism of uric acid.

It also asked the company that postmarketing surveillance should be conducted on the first 1,000 patients to assess safety and efficacy of the drug.

In a seperate development, Maharashtra’s health minister Rajesh Tope said that Cipla and Hetero have received emergency marketing approval for Remdesivir for the treatment of severe Covid-19 patients from the drug controller of India, a move that would help companies launch it officially in hospitals across the country.

The emergency approval is given to an unapproved therapy for compassionate use provided drug companies share the clinical data of the drug on patients where it is used. Officials from DCGI and Hetero and Cipla did not confirm this development to ET.

The other licensees of Gilead who are awaiting a nod from the drug regulator are Jubilant Pharma, Zydus Cadila, Dr Reddys.

Health

Bhutan adds 10 more coronavirus infections

The ministry of health in Bhutan said on Sunday that 10 more patients have been diagnosed with coronavirus in the country, which marks the largest daily increase in the number of cases in the country, the total number of coronavirus infections in the country stood at 43.

Thimphu:
A Bhutanese student in quarantine in capital Thimphu has tested positive for COVID-19, making it the third case in the country and the first Bhutanese national to be infected, the Health Ministry said Thursday.

As per the ministry, the student has returned from Britain recently and was in quarantine when tested for the virus.

The ministry has initiated contact tracing and most of the contacts were already put under quarantine. Around 25 people were tested for the virus of which only the student was tested positive.

Meanwhile, the country’s health minister has also informed that the ministry has called back the doctors who went abroad. Around 24 have returned and are currently in quarantine centers.

Bhutan currently has only around 3,000 health workers and as per the minister this number will not be able to deliver the services if the country enter into the worst-case scenario. Around 600 backup volunteers have been trained to carry out health screening and the ministry plans to train 5,000 more.

To meet the shortages, the ministry also plans to keep those working in private clinics for backup services. The country also plans to call resigned doctors, nurses and health workers to make up for shortage if faced with worst-case situation.

Health

Phase-1 trial: Adenovirus COVID-19 vaccine found safe, induces immune responses

Trial was carried out on 108 participants aged 18-60 in Wuhan

A phase-1 trial using a single dose of a vaccine (Ad5-nCoV) that uses a recombinant adenovirus type-5 vector that carries the genetic material that codes for spike glycoprotein of novel coronavirus was found to be safe, well-tolerated and able to generate immune responses against the virus. The adenovirus is a weakened common cold virus.

The trial was carried out on 108 participants aged 18-60 years in Wuhan, China, and had 36 participants each in the low, middle and high-dose groups.

The trial did not involve randomisation of participants and did not have a control arm. The results are based on short duration of follow-up. The results were published in the journal The Lancet.

Safety of the vaccine

The most common adverse reaction was pain at the injection site (58 participants or 54%), fever (50 participants), fatigue (47 individuals), headache (42 participants) and muscle pain (18 participants). Most adverse reactions reported were mild or moderate in severity. One participant who was given the higher dose vaccine reported severe fever, along with severe symptoms of fatigue, shortness of breath and muscle pain. However, these adverse reactions persisted for less than 48 hours. No serious adverse event was noted within 28 days post-vaccination.

80% success chance for Oxford vaccine trials, says Serum Institute chief

“As it was a first-in-human study of the adenovirus type-5 vectored COVID-19 vaccine, it was not designed to measure the vaccine efficacy,” they write. But they note that in animal studies, seven out of eight ferrets were protected when challenged by the virus 21 days after immunisation with the vaccine.

Immune responses

The vaccine was found to elicit neutralising antibodies, which peaked at day 28 post-vaccination, while rapid specific T-cell responses peaked at day 14 after vaccination. The antibody response to the vaccine in the high-dose group was slightly greater than that in the middle-dose and low-dose groups.

After 28 days, most participants had a four-fold increase in binding antibodies (35/36, 97% low-dose group; 34/36 (94%) middle-dose group, and 36/36, 100% in high-dose group). Meanwhile, 18 (50%) participants in the low-dose group, 18 (50%) in the middle-dose group, and 27 (75%) in the high-dose group showed neutralising antibodies against the virus.

WHO backs COVID-19 vaccine trials that deliberately infect participants

The vaccine also stimulated a rapid T cell response in the majority of volunteers, which was greater in those given the higher- and middle-doses of the vaccine, with levels peaking at 14 days after vaccination. About 83% (30 of 36) of low-dose participants, 97% (35 of 36) of middle-dose participants and 97% (35 of 36) of high-dose participants developed T cell responses at 14 days.

But 28 days after vaccination, the majority of recipients showed either a positive T cell response or had detectable neutralising antibodies against SARS-CoV-2 (low-dose group 28/36, 78%; middle-dose group 33/36, 92%; high-dose group 36/36, 100%).

Limitations

The pre-existing immunity to adenovirus type-5 vector used in the vaccine, regardless of the vaccine doses, could reduce the immune responses (both neutralising antibodies and T-cell response) to the virus and also lower the peak of the responses, particularly for neutralising antibodies immunity. The high pre-existing immunity might also have a negative effect on the persistence of the vaccine-elicited immune responses, they write. Recipients aged 45-60 years seemed to have lower seroconversion of neutralising antibody, compared with the younger recipients.

In the study, 44-56% of participants had high pre-existing immunity to adenovirus type-5, and had a less positive neutralising antibody and T-cell response to the vaccine, they note.

Only five (25%) participants of 20 in the low-dose group, seven (37%) participants of 19 in the middle dose group, and ten (63%) participants of 16 in the high dose group, who had high pre-existing immunity to adenovirus type-5, had at least a four-fold increase in neutralising antibody titre at day 28 post-vaccination.

Phase-2 trial

The researchers will be testing the low- and middle-dose vaccine in phase-2 trials. “We selected doses for the phase-2 study mainly on the basis of the safety profile of the candidate vaccines shown in the participants within seven days and 14 days post-vaccination,” they note.

The phase-2 trial will be a randomised, double-blinded and placebo-controlled trial. The trial has already been initiated in Wuhan to determine if the results can be replicated and to also assess the vaccine for safety up to six months after vaccination. The vaccine will be tested on 500 healthy adults — 250 volunteers will get the middle dose, 125 will get the low dose and 125 will receive a placebo. The trial will include participants aged over 60.R. Prasad : , The Hindu

Health

American’s rescue from Bhutan involves a king, a ventilator and an 8,000-mile journey

NEW DELHI – The 76-year old American tourist arrived at the hospital in Thimphu, the sleepy capital of Bhutan, on a cool day in early March.

His symptoms were perplexing. He complained of stomach trouble and breathlessness, but his vital signs were normal. There was one exception: The level of oxygen in his blood was so low that doctors thought the monitor was malfunctioning. On a hunch, they decided to test him for the novel coronavirus.

Bert Hewitt, a retiree from Maryland with a passion for hiking, would become the first confirmed coronavirus case in Bhutan, a country of 780,000 people nestled in the world’s highest mountains and famous for its pursuit of “gross national happiness.”

Hewitt’s prognosis was not good. He had high blood pressure, and he was a cancer survivor whose spleen had been removed, compromising his immune system. His condition deteriorated rapidly.

In other ways, however, Hewitt would turn out to be exceptionally lucky. His case received personal attention from Bhutan’s beloved king. He was evacuated back to the United States in a Gulfstream jet outfitted with a biocontainment unit. The 8,000-mile journey was so complex that Secretary of State Mike Pompeo later singled it out for praise – especially because the patient was “frankly expected to die.”

Hewitt’s survival is also a source of pride in Bhutan, a young democracy where the monarchy remains revered. The command “from his majesty was to really take care of him,” said Dechen Wangmo, the country’s health minister. “The whole nation was, I think, praying for Bert.”

Hewitt’s odyssey began in mid-February. He and his partner, Sandi Fischer, a 59-year-old psychologist from Los Angeles, planned to travel around India and Bhutan. They took a week-long cruise down the Brahmaputra River in northeastern India, stopping in small villages.

On the last night of the cruise, the staff prepared a sumptuous banquet, but Hewitt’s appetite had vanished. He could not eat a bite.

To reach Bhutan, Hewitt and Fischer flew north toward an unbroken line of Himalayan peaks, then descended into the valley that is home to the country’s only international airport.

Hewitt’s gastrointestinal problems worsened, he said, and he felt breathless. After an outing to the town of Punakha, where the pair mingled with locals at an annual festival, Hewitt could barely walk from the car to a cafe for a cup of tea.

At first, doctors in Thimphu believed Hewitt had a stomach bug. On March 4, he returned to the hospital. Within 24 hours, there was an answer: coronavirus.

For the Bhutanese authorities, it meant the threat they feared had arrived. Health officials rushed to trace Hewitt’s contacts. King Jigme Khesar Namgyel Wangchuck oversaw the process in person, staying through the night, said Dechen Wangmo, the health minister.

By the next morning, 73 direct contacts were moved to quarantine facilities. Another 225 indirect contacts were told to isolate at home. In the northeastern Indian state of Assam, health authorities traced nearly 600 people, including the staff of the river boat.

Hewitt and Fischer were moved to a new wing of Thimphu’s main hospital, which is named after Jigme Dorji Wangchuk, a previous king. The current monarch sent Hewitt a pair of blue silk pajamas and a bedspread.

The king constantly inquired as to the couple’s well-being. In a call with Fischer, he said he hoped to speak with Hewitt, a physicist by training, about black holes one day. “He was lovely and very solicitous and kind,” Fischer said. She also heard from Bhutan’s prime minister, Lotay Tshering, who is himself a doctor. Strangers sent letters and flowers to the hospital.

From his room, Hewitt could see a line of white Buddhist prayer flags fluttering on a ridge. Despite the efforts of a dedicated team of doctors and nurses, he became increasingly ill. The X-rays of his lungs were “horrendous,” Fischer said.

A doctor told Hewitt that the only option was to place him on a ventilator. It would be the last thing he remembered for 10 days.

Back in Maryland, Hewitt’s children were frantic. His elder daughter reached out to the government for help getting her father home. William Walters, deputy chief medical officer for operations at the State Department, approached Phoenix Air, an air charter company in Georgia with expertise in medical evacuations.

The nearest aircraft with a biocontainment unit was in Nairobi. It flew to Bhutan with a crew that included a nurse and a paramedic, a Phoenix executive told a Georgia newspaper. Fischer watched from a hospital window as Hewitt, still on a ventilator, was wheeled into a waiting ambulance. She thought she would never see him again.

The jet stopped in Kolkata, India; Dubai; the Greek island of Crete; Paris; and Newfoundland, Canada, to refuel and take on fresh crew members. None of them were allowed to leave the aircraft during the journey because they were transporting a contagious patient, the Phoenix executive said.

Early on March 14, more than 30 hours after the jet departed Bhutan, it landed in Maryland. Hewitt was transferred to the University of Maryland Medical Center in Baltimore, where his eldest daughter is the director of care management. Hewitt’s daughter and a spokeswoman for the hospital declined to respond to questions.

During the pandemic, the State Department has helped repatriate more than 85,000 Americans. Only 20 have been covid-19 patients. They include 14 passengers from the Diamond Princess cruise ship in Japan and six others who were evacuated via “dedicated biocontainment missions,” said Walters, the State Department medical official.

While each of the six had a “unique mix of challenges, none have matched the evacuation of the U.S. citizen from Bhutan,” he said. The other medical flights were from Nigeria, Djibouti, Chad and the Congo Republic.

Such evacuations cost upward of $200,000, Walters said, and families undertake to reimburse the government for the price of the journey.

Hewitt was on a ventilator for 10 days. His first memory is waking up with someone pressing on his head and calling his name. Hewitt said that a doctor there told him that “whatever they tried in Bhutan probably saved your life.” After about two weeks, he was transferred to a rehabilitation facility.

At first, he was too weak to press the call button to summon a nurse. Yet to his own surprise, he made a swift recovery. He had left Bhutan with nothing except his passport, which was returned to him in a biohazard bag.

Fischer also ultimately tested positive for the virus but remained asymptomatic. She was the only confirmed case traced back to Hewitt: None of their Bhutanese contacts, including their tour guide and driver, tested positive. Nor did the handful of their contacts tested in India. To date, Bhutan has recorded 15 coronavirus cases in total.

Last week, Hewitt was able to complete his former daily exercise regimen: a five-mile walk up and down hills in the woods next to his home. He and Fischer – who managed to return to California after seven weeks in Bhutan – talk every morning.

Hewitt believes he came within a few days of dying. He is at a loss to explain his recovery. “I still think it’s a miracle I survived,” he said.

An optimist by nature, he used to take a cavalier attitude toward things like travel insurance. “I’ll be a bit more careful in the future,” he said, then laughed. Pandemic or no, there aren’t any trips on the horizon: His daughter, he said, has threatened to confiscate his passport.
by Joanna Slater, The Washington Post

Health

‘Disciplined’ northeast emerges as model of Covid-19 management

NEW DELHI: The northeastern region, which has traditionally been disciplined, has emerged as the model of coronavirus management and the rest of the country should emulate it, Union minister Jitendra Singh said on Saturday.

He said people in the eight northeastern states – Sikkim, Arunachal Pradesh, Mizoram, Manipur, Meghalaya, Nagaland, Tripura and Assam – have been following the lockdown-related guidelines in letter and spirit.

“By tradition and by lifestyle, people of northeastern region are civilised and disciplined. That is why they could very easily follow the lockdown guidelines. There has been no problem in ensuring implementation of the lockdown-related guidelines there,” Singh told PTI.

He said within six years of the Modi government, the northeastern region has emerged as the model for development for the entire country.

“Similarly, during the lockdown due to Covid-19, entire northeast has become model for the whole country to emulate it,” he said, adding that the way people are adhering to these guidelines is commendable.

Singh said five out of eight northeastern states are free from this deadly virus now and Sikkim never had a single case throughout.

“The spread of the deadly virus in the northeastern region by far has been contained by the support of people and the administration. There has been day-to-day monitoring of the situation at the micro and macro level both by the state government and by the Ministry of Development of North Eastern Region (DoNER),” the minister said.

Singh, who holds multiple portfolios, including the minister of state in the Prime Minister’s Office and in DoNER, praised the work being done by women self-help groups in the northeastern region.

“There has been a rich tradition of women self-help groups in the northeastern region. These women help groups have been making masks for people. These masks are such creative and filled with colours that they can go with almost all kinds of clothes,” he said.

Singh said there is no shortage of essential commodities and medical equipment in the entire northeastern region.

“Prime Minister Narendra Modi’s scientific approach towards managing difficult situations guided us to ensure that there is no shortage of essential goods in the northeast, which is geographically important to the nation,” he said.

He said 350 tonnes of necessary goods have been delivered so far in the northeastern region via air cargo.

Singh said the first flight carrying such goods landed there as early as March 30 to ensure that people living in the remote corner of the country do not face any shortage of daily needs.

“I can say very confidently that the whole northeastern region is guiding the entire nation in the efficient ways to contain the pandemic,” he said.

To a question on reports that the Centre was considering reduction in pension, he said these were “manufactured news”.

“Why would the central government think to take such a step that too with pensioners? It is all manufactured news. People with vested interest are using it. There has been no thinking by the government on either stoppage or reduction of pension,” he clarified.

Singh said there also has been manufactured news about the Centre’s move to reduce the age of retirement of central government employees from the existing 60 years, which is “entirely incorrect”.

“There is no move to reduce the retirement age of the central government employees,” said the minister of state for personnel.

There are 48.34 lakh central government employees and 65.26 lakh pensioners.

Health

Two doctors infected in Assam; Coronavirus cases rose to 58, death 2

Guwahati: The total number of coronavirus cases in Assam rose to 58 with two junior doctors testing positive for the disease on Friday and the test report of a 16-year-old girl confirmed the infection after her death, Health minister Himanta Biswas Sarma said. Two infected junior doctors are from Guwahati Mediacal College and North Eastern Regional Dental College.

The girl was suffering from fever and a pain in her leg. When her condition deteriorated, she was admitted to B Barooah Cancer Hospital on Thursday where she died later, the minister said at a press conference.

Her sample, taken for COVID-19 testing, and was found to be positive. It is “very unfortunate as she did not get the necessary treatment”, he said.
“We will have to discuss with the Union Health Ministry whether we can declare that she died due to COVID-19 as we did not treat her for the disease. She was found to be positive after her death,” Sarma said.

The Kamrup (Metro) district administration has declared two hostels and areas around the Guwahati Medical College Hospital, the employers’ colony near the B Barooah Cancer Institute where the girl lived with her grandmother and certain areas in Kharghuli and Chandmari as containment zones.

Sarma said of the total cases in the state, 21 are active while 34 have been cured of the disease and one died.

The health minister said that a bus carrying 45 passengers had arrived in Silchar on Wednesday from Rajasthan’s Ajmer.

Three of them tested positive on Friday, taking the the total number of cases related to this particular group to eight. Thirty-three were negative and results of other tests are awaited, he said.

Since the passengers had gone home briefly after screening, several areas in four villages of Cachar district have been declared as containment zones, Sarma said, adding direct and indirect contact tracing was on and 185 people have been quarantined in facilities.

In the last 24 hours, Assam reported a sudden spike in the number of COVID-19 cases. Of the 11 cases reported since Thursday, nine have travel history.

After a post-graduate student of the medicine department of Guwahati Medical College Hospital tested positive for COVID-19, the facility has been closed for new patients and 386 people, including hospital superintendent, doctors, students and several workers, have been quarantined, the health minister said.

Their swab tests have been conducted and the results were expected by Friday night. The medical student was engaged in screening of COVID-19 patients from May 4, Sarma said.

A 55-year-old woman from Kharghuli Hills area of Guwahati has tested positive and admitted to GMCH. Her family members have also been quarantined.

The fourth person to test positive in Guwahati had returned from West Bengal on May 6 along with two others in a personal vehicle. The person has been admitted to Mahendra Mohan Choudhury Hospital while the other two have tested negative, Sarma said.

“This is the second case with travel history to West Bengal and we have asked the police department not to issue passes to those originating their journey from this state, except in humanitarian cases,” the minister said.

Sarma said that three positive cases in Guwahati with no travel or contact history indicates that traces of the novel coronavirus may be prevalent in the city.

“People should, however, not panic but strictly follow the guidelines and report to doctors in case they have influenza-like illness (ILI) and diarrhoea,” he said.

So far, 1,032 people have entered the state since May 6 through check posts at Srirampur and Chagalia along the Assam-West Bengal border from where they proceeded to the five screening centres at Kokrajhar, Guwahati, Tezpur, Jorhat and Silchar.

The minister also said that harassing doctors, nurses and health workers is a non-bailable offence under the Epidemic Control Act and the Disaster Management Act.

Health

South Korea’s COVID-19 success story

On Thursday, the Republic of Korea recorded no locally transmitted COVID-19 cases, prompting praise from UN Secretary-General António Guterres. UN News has been finding out, from two UN colleagues based in the capital, Seoul, how life is changing for the better.

Stephan Klingebiel is Director of UN Development Programme’s (UNDP) Global Policy Centre in Seoul, which fosters partnerships between the Republic of Korea and the developing world. He puts the country’s success down to self-discipline, effective measures and testing.

“Just a few weeks ago, family members and friends in Germany were afraid of my duty station. In the second half of February and early March, when the number of new confirmed Covid-19 cases peaked, South Korea seemed to be a real global hot spot. This impression has changed fundamentally: now, rather than being seen as an epicentre, South Korea seems to be an outstanding example of how to manage the crisis!

What is interesting to highlight is the fact that South Korea never experienced the kind of lockdown which is being implemented in many European and Northern American countries: shops stayed open, but also restaurants and many leisure facilities, such as saunas. It’s true that a lot of people have been working from home, but many companies and institutions never changed the fundamental structure of their working arrangements in the office.

And the Korean approach is highly efficient and effective. When I returned from Germany at the end of March, there was a well-functioning protocol in place. Before I left Frankfurt Airport, I was asked to download an app from the Korean Ministry of Health and Welfare, and a second, from the Ministry of Interior and Safety, once I landed.

Upon arrival, we were escorted outside the building for COVID-19 testing, and boarded a chartered bus to a police facility, to wait for the test results overnight. Food and other amenities were provided, and I received my results the following morning.

After my negative test result, the chartered bus took all the foreign passengers back to the airport, where we were asked not to use any form of public transport to return home (taxis are checked to make sure there are no arrival passengers using them). When I got home, I had to report back on my health status every day. I was also given a grocery box and a basic set of masks and hand sanitizer!”

“Thursday was the first time in 72 days that the number of local COVID-19 infections in Korea reached zero: even taking into account the “imported” cases, the number of confirmed patients has remained steady at around ten per day for the past two weeks.

However, it’s rare to see people without masks on, and the elderly, as well as families with young kids like myself, are staying at home as much as possible. Schools are closed, so my son opens his computer each morning to attend his online classes.

I continue to do my groceries, shopping, dry cleaning and food delivery online via mobile apps, and I wore a mask to the recent country-wide national assembly election, where voters had their temperature taken, and their hands disinfected. They were instructed to stand one metre apart, and given plastic gloves before casting our ballots.

However, with the warmer Spring weather, social distancing is gradually waning in my neighborhood, especially among the young and healthy: South Korea was never under a major lockdown – only voluntary, intensive social distancing – and the streets, shops, restaurants and buses have begun bustling again. Masks, once so difficult to get a hold of, are now easy to buy. Online church services have gone offline as people return to services, and gyms and bars have re-opened.

We all knew very clearly, thanks to the daily government news briefings, emergency alerts, web and mobile-based apps, and GPS trackers, what symptoms to be wary of, what to do and where to go for testing, which neighbourhood pharmacy carried masks that day, and which “infection locations” to avoid visiting.

This inundation of real-time public information is what has really helped South Korea throughout this crisis.